Undertested and Overpriced: Japan Issues First Conditional Approval of Stem Cell Product

Cell Stem Cell. 2016 Apr 7;18(4):436-7. doi: 10.1016/j.stem.2016.03.006.

Authors

Christopher McCabe¹, Douglas Sipp²

Affiliations

¹ University of Alberta, Edmonton, AB T6G 2R3, Canada.
² RIKEN Center for Developmental Biology, 2-2-3 Minatojima-minamimachi, Chuou-ku, Kobe 650-0047, Japan; Keio University School of Medicine, Shinjuku-ku, Tokyo 160-8582, Japan. Electronic address: sipp@cdb.riken.jp.

PMID: 27058935
DOI: 10.1016/j.stem.2016.03.006

No abstract available

Publication types

Letter

MeSH terms

Cell- and Tissue-Based Therapy / economics*
Cell- and Tissue-Based Therapy / standards*
Humans
Japan
Medical Device Legislation*
Regenerative Medicine
Stem Cells*